The trade-off — and there is often a trade-off — is the fact that glucagon agonism can maximize heart level and could add to side effects not found with single or dual agonists. We are going to address those intimately down below.This follows Novo Nordisk's playbook (Ozempic for diabetic issues vs Wegovy for weight problems — both semaglutide